Thirty-percent of Keytruda’s U.S. sales came from its lung-cancer indication.
Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma’s access to docs declines
Approximately 10% to 15% of lung cancer patients have never smoked and have developed the disease due to genetic alterations.
Get the most out of
Register for free and enjoy unlimited access to: